Epilepsy is primarily considered a neurological disorder characterized by an enduring predisposition to generate epileptic seizures due to abnormal neuronal activity in the brain rather than being classified as a form of neurodiversity per se. Epilepsy involves symptoms that may include sensory, motor, cognitive, and emotional features, and it often has identified underlying structural, genetic, infectious, metabolic, or autoimmune causes NICE CKS. While epilepsy is associated with cognitive, developmental, and neurobehavioral comorbidities such as learning disabilities, autism spectrum disorder, and attention deficit hyperactivity disorder, it is generally managed as a medical condition with distinct diagnostic and treatment pathways NICE CKS,NICE NG217.
Neurodiversity broadly refers to variations in neurodevelopmental profiles including autism, ADHD, and other neurodevelopmental conditions that reflect natural diversity in brain development and function. Although epilepsy shares neurodevelopmental overlaps and co-occurrences with these conditions, such as autism spectrum disorder, it is conventionally categorized as a neurological disorder marked by seizures, rather than a neurodivergent trait or identity as conceptualized in neurodiversity frameworks NICE CKS,NICE NG217.
Importantly, epilepsy management guidelines emphasize careful assessment of cognitive, developmental, and mental health comorbidities and recommend coordinated multidisciplinary care where such neurodevelopmental issues coexist with epilepsy NICE NG217. Recent literature on neurodivergence highlights the importance of recognizing distinct neurodevelopmental differences for individualized care and social inclusion Cobbaert et al. 2024 Avdeeva et al. 2025 Verma et al. 2026. This suggests a growing awareness of the broader neurodivergence landscape but does not explicitly redefine epilepsy itself as a form of neurodiversity.
In summary, epilepsy is best understood as a neurological disorder with possible neurodevelopmental and cognitive sequelae rather than as a form of neurodiversity, although individuals with epilepsy may also identify or be supported through neurodiversity-informed approaches when comorbid neurodevelopmental conditions exist NICE CKS,NICE NG217 Cobbaert et al. 2024 Avdeeva et al. 2025.
Key References
- NICE CKS: Epilepsy
- NICE NG217: Epilepsies in children, young people and adults
- NICE CKS: Febrile seizure
- SmPC: Epanutin 30mg/5ml oral Suspension
- SmPC: Epanutin Infatabs
- SmPC: Sodium Valproate Strandhaven 200 mg/5 ml Oral Solution
- SmPC: Epilim Chronosphere MR 100 mg modified release granules
- (Cobbaert et al., 2024): Neurodivergence, intersectionality, and eating disorders: a lived experience-led narrative review.
- (Avdeeva et al., 2025): Pregnancy and Childbirth in Neurodivergent Women: Shift Towards Personalized Maternity Care.
- (Verma et al., 2026): Teaching developmental neurobiology with inclusion and valuing of neurodivergent learners.